Top Markets
Coin of the day
Dogecoin Cash, Inc. Dogecoin Cash, Inc.

Dogecoin Cash, Inc.

DOGP
Kedudukan dalam Saham #38196
Dogecoin Cash, Inc., through its various divisions, offers online telemedicine... Dogecoin Cash, Inc., through its various divisions, offers online telemedicine referral services, enabling clients across the United States to obtain medical marijuana cards. A central offering is PrestoDoctor, a digital healthcare platform that facilitates virtual connections between individuals and licensed physicians via video conferencing for securing medical cannabis recommendations. Beyond its telehealth operations, the company is engaged in the creation of several product lines. These encompass lozenges crafted for relief, "Recover" β€” a potent, deeply penetrating therapeutic balm designed to ease discomfort in sore muscles, joints, and conditions like arthritis or back pain β€” and "Trauma Cream," a topical solution infused with a blend of cannabinoids and THC. Furthermore, Dogecoin Cash, Inc. intends to introduce high-end men's and women's fashion from various suppliers through its e-commerce site, www.cbds.com. The firm also holds intellectual property licenses pertaining to the production of medical cannabis edibles. Its business endeavors primarily target both the cannabidiol (CBD) and broader cannabis sectors. The entity, previously known as Cannabis Sativa, Inc., adopted the name Dogecoin Cash, Inc. in November 2024 and is headquartered in Mesquite, Nevada.
Harga Saham
$0.007
Modal Pasaran
$1.14M
Perubahan (1 hari)
-2.78%
Perubahan (1 tahun)
-81.13%
Negara
US
Perdagangan Dogecoin Cash, Inc. (DOGP)

Kategori

Sejarah pecahan saham untuk Dogecoin Cash, Inc. (DOGP)
Saham Dogecoin Cash, Inc. (simbol: DOGP) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 14, 2026.
Satu saham DOGP yang dibeli sebelum Aug 14, 2026 kini bersamaan dengan 0 saham DOGP.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa